Cleared Traditional

See Factor CT3™ (K233230) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K233230 · Epica International, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
267d
Days
Class 2
Risk

K233230 is an FDA 510(k) clearance for the See Factor CT3™. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Epica International, Inc. (Duncan, US). The FDA issued a Cleared decision on June 21, 2024 after a review of 267 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Epica International, Inc. devices

Submission Details

510(k) Number K233230 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2023
Decision Date June 21, 2024
Days to Decision 267 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
160d slower than avg
Panel avg: 107d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 210
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K233230.
MC2 Portable X-ray System
K241567 · Oxos Medical · Dec 2024
ARTIS icono (VE40A) (floor)
K241572 · Siemens Medical Solutions USA, Inc. · Oct 2024
Alphenix, INFX-8000V/B, INFX-8000V/S, V9.5
K233107 · Canon Medical Systems Corporation · Aug 2024
O-arm O2 Imaging System
K240465 · Medtronic Navigation, Inc. · Jun 2024
IntraOp Alignment System
K240199 · Alphatec Spine, Inc. · May 2024
Zenition 90
K240224 · Philips Medical Systems Nederlands B.V. · May 2024